Table 2.
Serum levels of CRP, TNFα, and IL-6 at Baseline and following the 12-week intervention.
Placebo (n = 13) | Vitamin D (n = 10) | |||
---|---|---|---|---|
|
||||
Baseline | 12 weeks | Baseline | 12 weeks | |
CRP (mg·L−1) | 3.8 ± 2.8 | 2.9 ± 2.9 | 2.8 ± 2.7 | 4.8 ± 3.6 |
TNFα (pg·mL−1) | 1.9 ± 1.3 | 1.9 ± 1.2 | 2.3 ± 1.1 | 2.1 ± 1.2 |
IL-6 (pg·mL−1) | 1.1 ± 0.6 | 1.2 ± 0.6 | 1.6 ± 0.7 | 1.5 ± 0.7 |
No main effects of time or group were detected (P>0.05). Values are means ± SD. CRP, C-reactive protein; TNFα, tumor necrosis factor alpha, IL-6, interleukin 6.